Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction
This study has been completed.
Medical University of Vienna
First Posted: July 17, 2007
Last Update Posted: April 30, 2013
Information provided by (Responsible Party):
Irene Lang, Medical University of Vienna
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||August 2012|
|Primary Completion Date:||August 2009 (Final data collection date for primary outcome measure)|
Adlbrecht C, Andreas M, Redwan B, Distelmaier K, Mascherbauer J, Kaider A, Wolzt M, Tilea IA, Neunteufl T, Delle-Karth G, Maurer G, Lang IM. Systemic endothelin receptor blockade in ST-segment elevation acute coronary syndrome protects the microvasculature: a randomised pilot study. EuroIntervention. 2012 Apr;7(12):1386-95. doi: 10.4244/EIJV7I12A218.